LONG TERM HOLDING CALL : : LAURUS LAB

FOR  INTRADAY LIVE MARKET TRADING TIPS WHATSAPP NOW 7772909587
A look at the shareholders of Laurus Labs Limited can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.With a market capitalization of 317b, Laurus Labs is rather large. We'd expect to see institutional investors on the register. Companies of this size are usually well known to retail investors, too. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. We can zoom in on the different ownership groups, to learn more about Laurus Labs.With returns of over 20%, Laurus Labs is by far the best performing pharmaceutical stock over the past three months. In comparison, its peer index, the Nifty Pharma, is struggling to make money for investors shedding a percent.In fact, barring Sun Pharma and Cipla 10-12% all the pharma companies were in the red in this period. Ongoing price erosion and limited number of launches in the US market, inventory destocking and higher raw material/logistic costs have led to the muted performance of the pharma space. Amid this, Laurus continues to outperform.
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the we've spotted with Laurus Labs .Ultimately the future is most important. You can access this free report on analyst forecasts for the company.